CompletedPhase 2/3

Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

Brazil42 participantsStarted 2010-06

Plain-language summary

The investigators purpose is to follow remitted patients from their previous study using transcranial direct current stimulation (tDCS); as to verify whether this treatment prevents relapse.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: Patients from previous studies (ID:USP-HU-001 and ID:USP-HU-002) who: * received tDCS and responded. * received tDCS + sertraline and responded. * received sertraline or placebo and did not respond, and thereafter received tDCS during the cross-over phase and responded. Exclusion criteria: Patients from previous studies who: * received tDCS and did not respond. * received tDCS + sertraline and did not respond. * received sertraline or placebo and responded. * did not respond during the crossover phase. * do not wish to participate in the present study.

What they're measuring

Relapse from depression

Timeframe: Week 4

Relapse from depression

Timeframe: Week 8

Relapse from depression

Timeframe: Week 12

Relapse from depression

Timeframe: Week 16

Relapse from depression

Timeframe: Week 20

Relapse from depression

Timeframe: Week 24

Trial details

NCT IDNCT01149213

SponsorUniversity of Sao Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

View on ClinicalTrials.gov More Major Depressive Disorder trials